Skip to main content

Table 4 Summary of the delayed post-procedural (day 28) angiography results

From: In vivo canine study of three different coatings applied to p64 flow-diverter stents: initial biocompatibility study

Animal number Medication Right CCA/ECA Left CCA/ECA Right SA Left SA
1 None p64 HPC-1, minimal stenosis p64 uncoated, patent p64 HPC-2, patent p64 HPC-3, patent
2 ASA p64 HPC-1, patent p64 uncoated, patent p64 HPC-2, severe stenosis p64 HPC-3, complete stenosis
3 ASA p64 HPC-2, patent p64 HPC-1, patent p64 HPC-3, patent p64 uncoated, severe stenosis
4 ASA + clopidogrel p64 HPC-2, patent p64 HPC-1, patent p64 HPC-3, patent p64 uncoated, patent
  1. ASA acetylsalicylic acid, CCA common carotid artery, ECA external carotid artery, SA subclavian artery